chr2-48646471-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006872.5(GTF2A1L):c.407A>T(p.Asn136Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,608,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N136S) has been classified as Uncertain significance.
Frequency
Consequence
NM_006872.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GTF2A1L | NM_006872.5 | c.407A>T | p.Asn136Ile | missense_variant | 6/9 | ENST00000403751.8 | |
STON1-GTF2A1L | NM_001198593.2 | c.2519A>T | p.Asn840Ile | missense_variant | 8/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GTF2A1L | ENST00000403751.8 | c.407A>T | p.Asn136Ile | missense_variant | 6/9 | 1 | NM_006872.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152026Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000738 AC: 18AN: 243740Hom.: 0 AF XY: 0.0000379 AC XY: 5AN XY: 131970
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1456800Hom.: 0 Cov.: 32 AF XY: 0.00000828 AC XY: 6AN XY: 724706
GnomAD4 genome AF: 0.000138 AC: 21AN: 152026Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74272
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 23, 2022 | The c.407A>T (p.N136I) alteration is located in exon 6 (coding exon 6) of the GTF2A1L gene. This alteration results from a A to T substitution at nucleotide position 407, causing the asparagine (N) at amino acid position 136 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at